Nathalie ROCHET

Dr. Nathalie ROCHET

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
PDF file
PBPascal Boileau
Pascal Boileau
CCChristopher Chuinard
Christopher Chuinard
YRYannick Roussanne
Yannick Roussanne
RBRyan T. Bicknell
Ryan T. Bicknell
NRNathalie ROCHET
Nathalie ROCHET
CTChristophe Trojani
Christophe Trojani
Although a reverse shoulder arthroplasty (RSA) can restore active elevation in the cuff deficient shoulder, it cannot restore active external rotation when both the infraspinatus and teres minor muscles are absent or atrophied. We hypothesized that a latissimus dorsi and teres major (LD/TM) transfer with a concomitant RSA would restore shoulder function and activities of daily living (ADLs). We prospectively followed 11 consecutive patients (mean age, 70 years) with a combined loss of active elevation and external rotation (shoulder pseudoparalysis and dropping arm) who underwent this procedure. All had severe cuff tear arthropathy (Hamada Stage 3, 4, or 5) and severe atrophy or fatty infiltration of infraspinatus and teres minor on preoperative MRI or CT-scan. The combined procedure was performed through a single deltopectoral approach in the same session. Postoperatively, mean active elevation increased from 70° to 148° (+78°) and external rotation from −18° to 18° (+36°). The Constant score, subjective assessment and ADLs improved. The combination of a RSA and LD/TM transfer restored both active elevation and external rotation in this selected subgroup of patients with a cuff deficient shoulder and absent or atrophied infraspinatus and teres minor. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

1 November 2005 in Biomaterials
Verified
Journal Article
Closed access
CVC. Vinatier
C. Vinatier
David MagneDavid Magne
David Magne
PWPierre Weiss
Pierre Weiss
CTC. Trojani
C. Trojani
NRNathalie ROCHET
Nathalie ROCHET
JGJérôme Guicheux
Jérôme Guicheux

2 November 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
FTFrédéric Torossian
Frédéric Torossian
BGBernadette Guerton
Bernadette Guerton
AAAdrienne Anginot
Adrienne Anginot
KAKylie A. Alexander
Kylie A. Alexander
CDChristophe Desterke
Christophe Desterke
MBMarie-Caroline Le Bousse-Kerdilès
Marie-Caroline Le Bousse-Kerdilès
Neurogenic heterotopic ossification (NHO) is the formation of ectopic bone generally in muscles surrounding joints following spinal cord or brain injury. We investigated the mechanisms of NHO formation in 64 patients and a mouse model of spinal cord injury–induced NHO. We show that marrow from human NHOs contains hematopoietic stem cell (HSC) niches, in which mesenchymal stromal cells (MSCs) and endothelial cells provide an environment supporting HSC maintenance, proliferation, and differentiation. The transcriptomic signature of MSCs from NHOs shows a neuronal imprinting associated with a molecular network required for HSC support. We demonstrate that oncostatin M (OSM) produced by activated macrophages promotes osteoblastic differentiation and mineralization of human muscle-derived stromal cells surrounding NHOs. The key role of OSM was confirmed using an experimental model of NHO in mice defective for the OSM receptor (OSMR). Our results provide strong evidence that macrophages contribute to NHO formation through the osteogenic action of OSM on muscle cells within an inflammatory context and suggest that OSM/OSMR could be a suitable therapeutic target. Altogether, the evidence of HSCs in ectopic bones growing at the expense of soft tissue in spinal cord/brain-injured patients indicates that inflammation and muscle contribute to HSC regulation by the brain-bone-blood triad.

1 November 2009 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
FBFlorian Boukhechba
Florian Boukhechba
TBThierry Balaguer
Thierry Balaguer
JMJean-François Michiels
Jean-François Michiels
KAKarin Ackermann
Karin Ackermann
DQDanielle Quincey
Danielle Quincey
NRNathalie ROCHET
Nathalie ROCHET
Studies on primary osteocytes, which compose >90–95% of bone cells, embedded throughout the mineralized matrix, are a major challenge because of their difficult accessibility and the very rare models available in vitro. We engineered a 3D culture method of primary human osteoblast differentiation into osteocytes. These 3D-differentiated osteocytes were compared with 2D-cultured cells and with human microdissected cortical osteocytes obtained from bone cryosections. Human primary osteoblasts were seeded either within the interspace of calibrated biphasic calcium phosphate particles or on plastic culture dishes and cultured for 4 wk in the absence of differentiation factors. Osteocyte differentiation was assessed by histological and immunohistological analysis after paraffin embedding of culture after various times, as well as by quantitative RT-PCR analysis of a panel of osteoblast and osteocyte markers after nucleic acid extraction. Histological analysis showed, after only 1 wk, the presence of an osteoid matrix including many lacunae in which the cells were individually embedded, exhibiting characteristics of osteocyte-like cells. Real-time PCR expression of a set of bone-related genes confirmed their osteocyte phenotype. Comparison with plastic-cultured cells and mature osteocytes microdissected from human cortical bone allowed to assess their maturation stage as osteoid-osteocytes. This model of primary osteocyte differentiation is a new tool to gain insights into the biology of osteocytes. It should be a suitable method to study the osteoblast-osteocyte differentiation pathway, the osteocyte interaction with the other bone cells, and orchestration of bone remodeling transmitted by mechanical loading and shear stress. It should be used in important cancer research areas such as the cross-talk of osteocytes with tumor cells in bone metastasis, because it has been recently shown that gene expression in osteocytes is strongly affected by cancer cells of different origin. It could also be a very efficient tool for drug testing and bone tissue engineering applications.

1 September 2005 in Biomaterials
Verified
Journal Article
Closed access
CTChristophe Trojani
Christophe Trojani
PWPierre Weiss
Pierre Weiss
JMJean-François Michiels
Jean-François Michiels
CVClaire Vinatier
Claire Vinatier
JGJérôme Guicheux
Jérôme Guicheux
NRNathalie ROCHET
Nathalie ROCHET

1 June 2006 in Biomaterials
Verified
Journal Article
Closed access
CTChristophe Trojani
Christophe Trojani
FBFlorian Boukhechba
Florian Boukhechba
JSJean-Claude Scimeca
Jean-Claude Scimeca
FVFanny Vandenbos
Fanny Vandenbos
JMJean-François Michiels
Jean-François Michiels
NRNathalie ROCHET
Nathalie ROCHET